Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHgCapital Trust plc Regulatory News (HGT)

Share Price Information for HgCapital Trust plc (HGT)

Share Price is delayed by 15 minutes
Get Live Data
374.50    11.50 (3.17%)
Bid:
367.50
Ask:
372.50
Spread: 5.00 (1.361%)
Market Cap: £1.70b
HGT Live PriceLast checked at - London Stock Exchange

Intraday HgCapital Trust plc Share Chart

Update re Subscription shares & NAV

4 Jun 2013 12:01

RNS Number : 2521G
HgCapital Trust PLC
04 June 2013
 



 

 

NAV of HgCapital Trust rises to £460.2 million on final exercise of Subscription shares

 

 

HgCapital Trust plc (the "Trust") announces that the deadline for submitting instructions in respect of the 31 May 2013 Subscription date, whereon holders of Subscription shares had the right to subscribe for Ordinary shares in the Trust at a price of 1,025 pence per share, has now passed.

 

The Trust can confirm that Subscription rights were exercised on 1,439,684 shares in total and the aggregate proceeds raised by the Trust in respect of such exercises will be £14,756,761.

 

Based on the 30 April 2013 reported NAV and adjusting for the new Ordinary share proceeds, which are expected in mid-June 2013, the pro-forma NAV of the Trust is estimated to be £460.2 million or 1,241.8 pence per share fully diluted* (1,243.6 pence per share basic) and liquid resources are estimated to be £155.5 million (35% of the pro-forma NAV). These figures have been adjusted to include the impact of the ATC realisation announced earlier this week.

 

\* The calculation of fully diluted earnings per share assumes that all outstanding subscription shares in issue are exercised at their price of 1,025 pence.

 

 

Further to the announcement dated 26 April 2013, the Trust has now appointed a Final Subscription Trustee to act on behalf of the holders of the 320,829 Subscription shares that have not as yet been exercised. It is currently expected that the Final Subscription Trustee will exercise the rights attaching to the remaining Subscription shares, at the Subscription price of 1,025p per share, following which the resulting Ordinary shares will be sold in the market and the proceeds (less costs) will be distributed pro rata to the holders of the shares.

 

In the event the remaining Subscription shares are exercised as above, the Subscription proceeds raised by the Trust in respect of the final Subscription date will be increased by a further £3,288,497. It is noted that the Subscription shares were issued free of charge to participants in the placing and open offer that took place in April 2010 and that the total proceeds raised through the open offer and subsequent Subscription share exercises will be in excess of £110million (before costs).

 

Pursuant to the instructions received from shareholders and subject to the receipt of relevant instructions from the Final Subscription Trustee, the Board of the Trust will shortly approve the issue and allotment of 1,760,513 Ordinary shares. The shares will be admitted to trading in due course, and a further announcement will be released in this regard.

 

An application has been made to the FCA for the suspension of the entire Subscription share class from the Official List with effect from 7:30am on 5 June 2013 and for the cancellation of the entire Subscription share class from the Official List at 8.00am on 3 July 2013.

 

 

The information in this announcement should be read in conjunction with the full text of the Circular dated 25 April 2013. Capitalised terms used but not defined in this announcement shall, unless the context otherwise requires, bear the meaning given to them in the Circular.

 

- Ends -

For further details:

Stephen Bough: +44 (0)20 7089 7888

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFZLFBXQFBBBB
Date   Source Headline
18th Sep 20237:00 amRNSHalf-year Report and Dividend Declaration
5th Sep 20238:00 amRNSHg agrees to sale of Commify to ECI Partners
17th Aug 20238:00 amRNSHg agrees to partial sale of TeamSystem
4th Aug 20237:15 amRNSEdison issues review on HG Capital Trust (HGT)
20th Jul 20237:00 amRNSHg announces investment in Nomadia
19th Jun 20237:00 amRNSAzets Group secures investment from PAI to join Hg
18th May 20239:00 amRNSHg announces investment in GTreasury
17th May 20235:21 pmRNSResult of AGM
15th May 20237:00 amRNSQ1 2023 Report to 31 March 2023
12th May 20234:53 pmRNSBlock listing Interim Review
4th Apr 202310:04 amRNSDirector/PDMR Shareholding
3rd Apr 20233:51 pmRNSUpdate on HGT's Commitment to Hg's Saturn 3 Fund
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202310:35 amRNSDirector/PDMR Shareholding
28th Mar 202312:24 pmRNSDirector/PDMR Shareholding
16th Mar 20232:14 pmRNSHgCapital Trust results summary with Doceo
15th Mar 202310:55 amRNSDirector/PDMR Shareholding
13th Mar 202310:51 amRNSUpdate on Silicon Valley Bank
13th Mar 20237:00 amRNSAnnual Results & Notice of Annual General Meeting
13th Mar 20237:00 amRNSAnnual Financial Report
31st Jan 20234:50 pmRNSBlock listing Interim Review
13th Dec 20227:00 amRNSHg agrees to sale of Transporeon
16th Nov 20227:00 amRNSEdison issues update on HgCapital Trust (HGT)
14th Nov 20227:00 amRNS3rd Quarter Results
1st Nov 202210:10 amRNSTotal Voting Rights
14th Oct 20227:00 amRNSTransaction in Own Shares
5th Oct 20227:00 amRNSIdeagen and ProcessMAP to Combine
4th Oct 20228:25 amRNSTrustQuay Secures Hg Investment
4th Oct 20227:00 amRNSTrustQuay Secures Hg Investment
13th Sep 20227:46 amRNSEdison issues update on HgCapital Trust (HGT)
12th Sep 20227:00 amRNSHgCapital Trust Interim Results 2022
12th Sep 20227:00 amRNSHalf-year Report
2nd Aug 20223:38 pmRNSHolding(s) in Company
20th Jul 20225:50 pmRNSHolding(s) in Company
14th Jul 20221:00 pmRNSHg announces a partial sale of Intelerad
7th Jul 20224:40 pmRNSReplacement: Director/PDMR Shareholding
6th Jul 20227:30 amRNSHg announces further investment in team.blue
5th Jul 20221:43 pmRNSDirector/PDMR Shareholding
4th Jul 20225:18 pmRNSDirector/PDMR Shareholding
28th Jun 20224:00 pmRNSNorstella announces merger agreement with Citeline
24th Jun 20227:00 amRNSHGT Board note agreement on acquisition of Ideagen
14th Jun 20227:00 amRNSHg agrees sale of MEDIFOX DAN to ResMed for US$1bn
9th Jun 20223:56 pmRNSInvestment in TigerRisk Partners
8th Jun 20227:00 amRNSHg further invests in The Access Group
17th May 20226:00 pmRNSHg agrees the sale of itm8 to Axcel
17th May 20227:00 amRNSEdison issues review on HgCapital Trust (HGT)
13th May 20224:54 pmRNSBlock listing Interim Review
10th May 20225:34 pmRNSResult of AGM
9th May 20227:00 amRNS1st Quarter Results
3rd May 20223:23 pmRNSAGM Update - Withdrawal of AGM Resolution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.